Phase I trial: CD19-targeted CAR T-cells in patients with residual CLL following initial purine analog-based therapy Meeting Abstract
| Authors: | Geyer, M.; Park, J.; Rivière, I.; Senechal, B.; Hsu, M.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R. |
| Abstract Title: | Phase I trial: CD19-targeted CAR T-cells in patients with residual CLL following initial purine analog-based therapy |
| Meeting Title: | 4th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 16 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2016 Sep 7-10 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-09-01 |
| Start Page: | S48 |
| Language: | English |
| ACCESSION: | 117709162 |
| DOI: | 10.1016/j.clml.2016.07.069 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Accession Number: 117709162 -- Entry Date: In Process -- Revision Date: 20160829 -- Publication Type: Meeting Abstract: CLL-123 -- Supplement Title: Sep2016 Supplement 2 -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101525386. -- Source: cin20 |
